DESTINY-Breast03 Phase 3 Study Results

ASCO/ESMO BC Presentation Materials ENHERTU® 1. DESTINY-Breast04 data - Modi S et al., ASCO 2022 #LBA3 Plenary Session 2. Retrospective study to estimate the prevalence of HER2 low BC - Viale G et al., ASCO 2022 #1087 Poster 3. DESTINY-Breast03 safety follow up - Hamilton E et al., ASCO 2022 #1000 Oral 4. DESTINY-Breast03 patient-reported outcomes - Curigliano G et al., ESMO BC 2022 #1630 Oral 5. TUXEDO-1 primary analysis - Bartsch R et al., ESMO BC 2022 #165 Mini Oral 6. Primary analysis of Ph1b study in combination with nivolumab Hamilton E et al., ESMO BC 2022 #1620 Oral - 7. Preliminary results from DESTINY-Breast07 & 08 studies - Andre F et al., ASCO 2022 #3025 Poster Daiichi-Sankyo 1

View entire presentation